Cargando…
The interface of COVID-19, diabetes, and depression
Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connecte...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886346/ https://www.ncbi.nlm.nih.gov/pubmed/35253006 http://dx.doi.org/10.1007/s44192-022-00007-0 |
_version_ | 1784660650889314304 |
---|---|
author | Steenblock, Charlotte Schwarz, Peter E. H. Perakakis, Nikolaos Brajshori, Naime Beqiri, Petrit Bornstein, Stefan R. |
author_facet | Steenblock, Charlotte Schwarz, Peter E. H. Perakakis, Nikolaos Brajshori, Naime Beqiri, Petrit Bornstein, Stefan R. |
author_sort | Steenblock, Charlotte |
collection | PubMed |
description | Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connected forming a vicious cycle. Firstly, depressed individuals show a higher risk of developing diabetes and patients with diabetes have a higher risk of developing symptoms of depression. Secondly, patients with diabetes have a higher risk of developing severe COVID-19 as well as of experiencing breakthrough infections. Thirdly, in both patients with type 2 diabetes and in COVID-19 survivors the prevalence of depression seems to be increased. Fourthly, lockdown and quarantine measurements during the COVID-19 pandemic has led to an increase in depression. Therefore, it is of importance to increase the awareness of this interface between depression, diabetes and COVID-19. Finally, as symptoms of post-COVID, diabetes and depression may be overlapping, there is a need for educating skilled personnel in the management of these comorbidities. |
format | Online Article Text |
id | pubmed-8886346 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-88863462022-03-01 The interface of COVID-19, diabetes, and depression Steenblock, Charlotte Schwarz, Peter E. H. Perakakis, Nikolaos Brajshori, Naime Beqiri, Petrit Bornstein, Stefan R. Discov Ment Health Review Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connected forming a vicious cycle. Firstly, depressed individuals show a higher risk of developing diabetes and patients with diabetes have a higher risk of developing symptoms of depression. Secondly, patients with diabetes have a higher risk of developing severe COVID-19 as well as of experiencing breakthrough infections. Thirdly, in both patients with type 2 diabetes and in COVID-19 survivors the prevalence of depression seems to be increased. Fourthly, lockdown and quarantine measurements during the COVID-19 pandemic has led to an increase in depression. Therefore, it is of importance to increase the awareness of this interface between depression, diabetes and COVID-19. Finally, as symptoms of post-COVID, diabetes and depression may be overlapping, there is a need for educating skilled personnel in the management of these comorbidities. Springer International Publishing 2022-03-01 /pmc/articles/PMC8886346/ /pubmed/35253006 http://dx.doi.org/10.1007/s44192-022-00007-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Steenblock, Charlotte Schwarz, Peter E. H. Perakakis, Nikolaos Brajshori, Naime Beqiri, Petrit Bornstein, Stefan R. The interface of COVID-19, diabetes, and depression |
title | The interface of COVID-19, diabetes, and depression |
title_full | The interface of COVID-19, diabetes, and depression |
title_fullStr | The interface of COVID-19, diabetes, and depression |
title_full_unstemmed | The interface of COVID-19, diabetes, and depression |
title_short | The interface of COVID-19, diabetes, and depression |
title_sort | interface of covid-19, diabetes, and depression |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886346/ https://www.ncbi.nlm.nih.gov/pubmed/35253006 http://dx.doi.org/10.1007/s44192-022-00007-0 |
work_keys_str_mv | AT steenblockcharlotte theinterfaceofcovid19diabetesanddepression AT schwarzpetereh theinterfaceofcovid19diabetesanddepression AT perakakisnikolaos theinterfaceofcovid19diabetesanddepression AT brajshorinaime theinterfaceofcovid19diabetesanddepression AT beqiripetrit theinterfaceofcovid19diabetesanddepression AT bornsteinstefanr theinterfaceofcovid19diabetesanddepression AT steenblockcharlotte interfaceofcovid19diabetesanddepression AT schwarzpetereh interfaceofcovid19diabetesanddepression AT perakakisnikolaos interfaceofcovid19diabetesanddepression AT brajshorinaime interfaceofcovid19diabetesanddepression AT beqiripetrit interfaceofcovid19diabetesanddepression AT bornsteinstefanr interfaceofcovid19diabetesanddepression |